Insider trading plan: Travere (TVTX) holder to sell 8,135 shares on NASDAQ

Rhea-AI Filing Summary

Travere Therapeutics insider plans another stock sale. A person identified in the filing plans to sell 8,135 shares of Travere Therapeutics common stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of 244,153.28, when 89,472,327 shares were outstanding as of the notice. The shares were acquired on 01/23/2026 via an option granted on 01/31/2020 and paid for in cash.

Over the prior three months, Eric M. Dube at a San Diego address sold 92,872 Travere common shares on 10/28/2025 for 2,821,217.14 and 27,128 shares on 10/29/2025 for 817,045.37. The signer represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8135	244153.28	89472327	01/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/23/2026	Option Granted - 01/31/2020	Issuer			8135	01/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric M. Dube 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	10/28/2025	92872	2821217.14
Eric M. Dube 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	10/29/2025	27128	817045.37

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for TVTX describe?

The Form 144 notice for Travere Therapeutics (TVTX) describes a planned sale of 8,135 shares of the company’s common stock on NASDAQ, along with details on how and when the shares were acquired.

How many Travere Therapeutics (TVTX) shares are planned for sale in this filing?

The notice covers a planned sale of 8,135 shares of Travere Therapeutics common stock, with an aggregate market value stated as 244,153.28 at the time of the filing.

What were recent Travere Therapeutics (TVTX) share sales by the same person?

In the past three months, Eric M. Dube sold 92,872 Travere common shares on 10/28/2025 for 2,821,217.14 and 27,128 shares on 10/29/2025 for 817,045.37.

How were the TVTX shares in this Form 144 acquired and paid for?

The 8,135 shares were acquired on 01/23/2026 through an option granted on 01/31/2020, and the filing states the shares were paid for in cash on the acquisition date.

On which exchange will the Travere Therapeutics (TVTX) shares be sold and through which broker?

The filing indicates the common shares are to be sold on the NASDAQ through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island.

What representation does the seller make about Travere Therapeutics (TVTX) information?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Travere’s current or prospective operations that has not been publicly disclosed.